首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1566193

筆式注射器市場規模、佔有率、成長分析、按類型、按療法、按最終用戶、按地區 - 行業預測，2024-2031 年

Injection Pen Market Size, Share, Growth Analysis, By Type, By Therapy, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年10月03日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球筆式注射器市場規模估值為450億美元，從2023年的485.7億美元成長到2031年的894.3億美元，預計在預測期內（2024-2031年）複合年成長率為7.93%。

由於慢性病的增加、對以患者為中心的護理以及醫療保健技術的進步等綜合因素的影響，全球筆式注射器市場正在經歷顯著成長。這個轉型市場分為產品類型、治療類型和最終用途，凸顯了一次性和可重複使用筆式注射器所扮演的重要角色。一次性筆式注射器因其成本效益和便利性而被廣泛採用，特別是在資源有限的環境和新興經濟體中。特別是，易於使用的胰島素輸送系統（例如 GLP-1 筆）正在推動需求。隨著競爭格局的加劇，這些設備已成為主要市場參與者的重點關注點。此外，全球筆式注射器市場呈現多樣化的區域動態，其中北美由於醫療保健行業領導者的集中和許多製造商向該地區擴張而處於主導。美國作為筆式注射器生產和創新的關鍵中心脫穎而出，進一步鞏固了其在塑造市場趨勢和滿足對高效注射解決方案不斷成長的需求方面的作用。不斷變化的醫療需求和技術進步的結合可能會在可預見的未來保持筆式注射器市場的成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Novo Nordisk A/S（Denmark）
Eli Lilly And Company（US）
Sanofi（France）
Ypsomed Holding AG（Switzerland）
Becton, Dickinson and Company（US）
Merck KGaA（Germany）
AstraZeneca（UK）
Owen Mumford（UK）
Sun Pharmaceutical Industries Ltd（India）
Pfizer Inc.（US）
Biocon（India）
Lupin（India）
Wockhardt Ltd.（India）
Medtronic（US）
Gerresheimer AG（Germany）
Shaily Engineering Plastics Ltd.（India）
SHL Medical AG（Switzerland）
Emperra GmbH E-Health Technologies（Germany）
Nemera France SAS（France）
Jiangsu Delfu Medical Device Co., Ltd.（China）
Solteam Medical（China）
Stevanato Group（Italy）
Wanhai Medical Instruments Co., Ltd.（China）

簡介目錄

Product Code: SQMIG35A2646

Global Injection Pen Market size was valued at USD 45 billion in 2022 and is poised to grow from USD 48.57 billion in 2023 to USD 89.43 billion by 2031, growing at a CAGR of 7.93% during the forecast period (2024-2031).

The global injection pen market is witnessing substantial growth due to a convergence of factors such as increasing chronic disease prevalence, a focus on patient-centric care, and advancements in healthcare technology. This transformative market, categorized into product type, therapy type, and end use, highlights the significant roles of both disposable and reusable injection pens. Disposable injection pens, praised for their cost-effectiveness and convenience, have seen heightened adoption, particularly in resource-limited settings and emerging economies. Within the therapy-specific segment, insulin pens dominate, influenced by the rising global diabetes rate and the growing elderly population that drives demand for user-friendly insulin delivery systems, notably GLP-1 pens. These devices represent a significant focus for key market players amid a competitive landscape. Moreover, the global injection pen market exhibits varied regional dynamics, with North America leading the charge, thanks to its concentration of healthcare industry leaders and numerous manufacturers expanding their footprint within the region. The United States stands out as a pivotal hub for injection pen production and innovation, further solidifying its role in shaping market trends and addressing the growing demand for efficient injection solutions. With a combination of evolving medical needs and technological progress, the injection pen market is positioned for continued expansion in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Injection Pen market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Injection Pen Market Segmental Analysis

Global Injection Pen Market is segmented by Type, Therapy, End User, and region. Based on Type, the market is segmented into Disposable Injection Pens, and Reusable Injection Pens. Based on Therapy, the market is segmented into Diabetes, Growth Hormone Therapy, Osteoporosis, Fertility, Obesity, and Other Therapies. Based on End User, the market is segmented into Home Care Settings, Hospitals & Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Injection Pen Market

The integration of advanced technologies into drug delivery systems serves as a significant market driver for the global Injection Pen market. Innovations such as electronic dose memory, Bluetooth connectivity for data tracking, and precision dose delivery mechanisms have revolutionized patient experiences and treatment outcomes. These enhancements make injection pens more user-friendly and accessible, fostering greater adoption among patients, caregivers, and healthcare professionals alike. By improving ease of use and ensuring accurate dosing, these technological advancements not only elevate patient satisfaction but also bolster adherence to prescribed therapies, stimulating market growth and establishing injection pens as essential tools in modern healthcare management.

Restraints in the Global Injection Pen Market

One significant market restraint impacting the global injection pen market is the affordability and accessibility challenges in developing regions. Patients in these areas often grapple with the high costs associated with injection pens and related therapies, which can pose a substantial financial burden, especially in regions with lower economic development. Additionally, limited healthcare infrastructure restricts both the availability and distribution of these advanced drug delivery devices, further hindering access for patients who rely on them for chronic disease management. Consequently, these barriers have a pronounced effect on market growth and the overall adoption of injection pens in these underserved populations.

Market Trends of the Global Injection Pen Market

The global injection pen market is witnessing a significant trend towards personalized and connected solutions that enhance patient engagement and medication adherence. As healthcare increasingly embraces digitalization, the incorporation of advanced connectivity features in injection pens allows for real-time monitoring of patient compliance and tracking of administered doses. This transformation is shifting traditional injection pens into smart devices that facilitate remote management of patients, offering insights into their medication routines. Consequently, pharma companies and manufacturers are investing in research and development to create innovative injection pens that leverage data sharing and technology to improve patient outcomes and streamline healthcare delivery.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Technology Analysis
Supply Chain Analysis
Trade Analysis
Value Chain Analysis
Regulatory Landscape
Patent Analysis
Pricing Analysis
Customer & Buying Criteria Analysis
Case Study Analysis

Injection Pen Market by Type

Market Overview
Disposable Injection Pens
Reusable Injection Pens

Injection Pen Market by Therapy

Market Overview
Diabetes
- Insulin
- Glucagon-Like Peptide-1
Growth Hormone Therapy
Osteoporosis
Fertility
Obesity
Other Therapies

Injection Pen Market by End User

Market Overview
Home Care Settings
Hospitals & Clinics

Injection Pen Market Size by Region

Market Overview
North America
- US
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Novo Nordisk A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly And Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocon (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lupin (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wockhardt Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shaily Engineering Plastics Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SHL Medical AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emperra GmbH E-Health Technologies (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nemera France SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiangsu Delfu Medical Device Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solteam Medical (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stevanato Group (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wanhai Medical Instruments Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments